← Evidence map

ArticleFrontiers in aging neuroscience2023

Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study.

Jae-Yong Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37122380